WebChronTech Pharma AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis March 2024 50 pages ID: C6E5EF219CBBEN BAC Reports US$ 499.00 ChronTech Pharma AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis Enhanced SWOT Analysis (+ … WebSep 27, 2015 · Referring to the press release published on September 25, 2015 by Fastilium Property Group AB (previously ChronTech Pharma AB), the company will carry out a reversed split in relations 1:100. The share will be traded under new International Securities Identification Number aka ISIN code with effect from October 1, 2015.
Fawn Creek Township Map - Locality - Kansas, United States
WebApr 18, 2011 · ChronTech claims a Phase IIa study has confirmed that therapy using ChronVac-C administered by electroporation resulted in rapid antiviral responses in HCV patients who also received... WebApr 18, 2011 · About ChronTech Pharma ChronTech develops the therapeutic DNA vaccines ChronVac-C® and ChronVac-B for chronic hepatitis C virus and hepatitis B … ontario weather by month
ChronTech Pharma
WebDeveloper ChronTech Pharma Class Antivirals; DNA vaccines; Hepatitis C vaccines Mechanism of Action Gene transference; Immunostimulants Orphan Drug Status Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. ... WebChronTech Pharma Evaluate Home Vantage Pharmaceutical Companies Chrontech Pharma Sorry, we didn't find any related vantage articles. Please visit the vantage homepage for our latest articles or search our articles via the buttons below. Vantage homepage Search articles Our latest articles February 24, 2024 WebChrontech Pharma Ab Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2009-02-02 Filing date 2010-01-29 Publication date 2011-01-06 2009-02-02 Priority to US14929909P priority Critical ionic-rating